Cite

HARVARD Citation

    Pulusu, S. et al. (n.d.). P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). Journal of Crohn's and colitis. pp. S395-S396. [Online]. 
  
Back to record